Publication date: May 30, 2026
Independent community pharmacies serve as critical healthcare access points in rural areas, yet they consistently underperform chain pharmacies on contraceptive access measures. This narrative commentary draws on mystery caller studies, implementation research, and policy analyses to examine pharmacy-based contraceptive access in the United States (US). Using emergency contraception (EC) as a case study, we show that independent pharmacies stock EC at dramatically lower rates than chains (e. g., 14. 6% vs. 76. 3% in West Virginia), provide less accurate information about purchase requirements and timing, and impose more barriers to access. Because independent pharmacies account for 76. 5% of pharmacies in rural areas, this disparity concentrates contraceptive inaccessibility in communities already facing the highest rates of unintended pregnancy, maternal mortality, and maternity care deserts. This pattern extends beyond EC to pharmacist-prescribed contraception and over-the-counter daily oral contraceptives. These disparities reflect systemic barriers, such as inadequate reimbursement, limited training infrastructure, and absence of corporate support, rather than failures of individual pharmacies. Drawing on implementation research and the success of West Virginia’s COVID-19 vaccination model, this paper proposes coordinated, sector-specific strategies to transform independent pharmacies from barriers into bridges for rural women’s contraceptive access.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Basel | contraceptive access |
| Corporate | independent pharmacy |
| Deserts | pharmacist |
| Healthcare | reproductive health |
| Virginia | women’s health |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | emergency |
| drug | DRUGBANK | Spinosad |
| disease | MESH | COVID-19 |
| disease | MESH | maternal deaths |
| disease | MESH | plan |
| disease | MESH | CVS |
| drug | DRUGBANK | Stavudine |
| disease | MESH | face |
| disease | MESH | pregnancy complications |
| disease | MESH | preterm birth |
| disease | MESH | death |
| drug | DRUGBANK | Levonorgestrel |
| drug | DRUGBANK | Etoperidone |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | MESH | confusion |
| disease | MESH | mul |
| drug | DRUGBANK | Huperzine B |
| disease | MESH | sexually transmitted infection |
| drug | DRUGBANK | Trestolone |
| drug | DRUGBANK | Guanosine |
| drug | DRUGBANK | Ilex paraguariensis leaf |
| disease | MESH | Burns |
| drug | DRUGBANK | Carboxyamidotriazole |
| pathway | REACTOME | Release |
| disease | MESH | injury |